Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI takes on tiny colon polyps: a game changer for routine scopes?

NCT ID NCT07362524

Knowledge-focused Sponsor: Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence (AI) system can help doctors in general hospitals accurately decide how to manage small colon polyps (5mm or smaller) during a colonoscopy. About 363 adults with at least one small polyp will be randomly assigned to have their polyps assessed with or without AI assistance. The goal is to see if AI can safely guide the "predict, resect, and discard" or "diagnose and leave" strategies, potentially reducing unnecessary polyp removal and lab costs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 363 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Agree to participate in this prospective randomized controlled study; 2. Age ≥18 years for colonoscopy; 3. At least one colorectal diminutive polyp (size \<=5mm) found during examination; Exclusion Criteria: 1. Already participating in other clinical trials, having signed informed consent and being in the follow-up period of other clinical trials; 2. Already participating in drug clinical trials and being in the washout period of experimental or control drugs; 3. History of drug or alcohol abuse or psychological disorders in the past five years; 4. Pregnant or lactating patients; 5. Known polyposis syndromes; 6. Patients with gastrointestinal bleeding; 7. Previous history of inflammatory bowel disease, colorectal cancer, or colorectal surgery; 8. Patients with contraindications to tissue biopsy; 9. Previous history of allergic reactions to bowel cleansing agent components; 10. Suffering from intestinal obstruction or perforation, toxic megacolon, heart failure (Grade III or IV), severe cardiovascular disease, severe liver failure, or renal insufficiency, etc.; 11. Patient's bowel preparation BBPS score \<6 for this colonoscopy; 12. Researchers consider the patient unsuitable for trial participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal polyps are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal adenoma polyp of large intestine

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal polyps

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nantong First People's Hospital

    Nantong, Jiangsu, 200127, China

  • Wuxi Ninth People's Hospital

    Wuxi, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.